Virtus Fund Advisers’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $1.42M | Buy |
29,077
+19,575
| +206% | +$953K | 0.01% | 267 |
|
|
2017
Q3 | $513K | Sell |
9,502
-591
| -6% | -$31.9K | 0.01% | 284 |
|
|
2017
Q2 | $590K | Sell |
10,093
-301
| -3% | -$17.6K | 0.01% | 297 |
|
|
2017
Q1 | $407K | Sell |
10,394
-10,025
| -49% | -$393K | ﹤0.01% | 346 |
|
|
2016
Q4 | $458K | Hold |
20,419
| – | – | ﹤0.01% | 342 |
|
|
2016
Q3 | $464K | Hold |
20,419
| – | – | ﹤0.01% | 341 |
|
|
2016
Q2 | $486K | Buy |
20,419
+6,339
| +45% | +$151K | ﹤0.01% | 343 |
|
|
2016
Q1 | $287K | Sell |
14,080
-3,049
| -18% | -$62.1K | ﹤0.01% | 385 |
|
|
2015
Q4 | $881K | Sell |
17,129
-180
| -1% | -$9.26K | 0.01% | 292 |
|
|
2015
Q3 | $738K | Sell |
17,309
-25,726
| -60% | -$1.1M | 0.01% | 315 |
|
|
2015
Q2 | $1.96M | Buy |
+43,035
| New | +$1.96M | 0.01% | 309 |
|
|
2014
Q3 | – | Sell |
-3,147
| Closed | -$92K | – | 2221 |
|
|
2014
Q2 | $92K | Buy |
+3,147
| New | +$92K | ﹤0.01% | 1456 |
|